Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Beryl Drugs Debt & Borrowing: ₹2.39 Cr

Beryl Drugs Ltd (BSE: 524606) has submitted its initial disclosure confirming it is not identified as a Large Corporate as of March 31, 2026. The company reported outstanding borrowings of ₹2.39 Crore, falling below the SEBI threshold for large corporate classification.

Key figures
Value₹2.39 Cr
Source

BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Beryl Drugs Ltd: key numbers

Share price
₹25.60
Market cap
₹12.98 Cr
Revenue (annual)
₹18.82 Cr
Net profit (annual)
₹0.42 Cr
P/E (TTM)
20.8×Sector 48.7×
Promoter holding
27.97%+0.15% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Beryl Drugs Ltd

All →

Other debt & borrowing announcements

All →